74 related articles for article (PubMed ID: 12759155)
21. A longitudinal analysis of cannabis use and mental health symptoms among gay, bisexual, and other men who have sex with men in Vancouver, Canada.
Chou FY; Armstrong HL; Wang L; Bacani N; Lachowsky NJ; Patterson TL; Walsh Z; Olarewaju G; Card KG; Roth EA; Hogg RS; Moore DM
J Affect Disord; 2019 Mar; 247():125-133. PubMed ID: 30665075
[TBL] [Abstract][Full Text] [Related]
22. Cannabis and mental illness: a review.
Lowe DJE; Sasiadek JD; Coles AS; George TP
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):107-120. PubMed ID: 30564886
[TBL] [Abstract][Full Text] [Related]
23. Assessing Energy Intake in Daily Life: Signal-Contingent Smartphone Application Versus Event-Contingent Paper and Pencil Estimated Diet Diary.
Wouters S; Thewissen V; Duif M; Lechner L; Jacobs N
Psychol Belg; 2016 Dec; 56(4):357-369. PubMed ID: 30479445
[TBL] [Abstract][Full Text] [Related]
24. Affect and cannabis use in daily life: a review and recommendations for future research.
Wycoff AM; Metrik J; Trull TJ
Drug Alcohol Depend; 2018 Oct; 191():223-233. PubMed ID: 30149283
[TBL] [Abstract][Full Text] [Related]
25. Mental Health-related Emergency Department Visits Associated With Cannabis in Colorado.
Hall KE; Monte AA; Chang T; Fox J; Brevik C; Vigil DI; Van Dyke M; James KA
Acad Emerg Med; 2018 May; 25(5):526-537. PubMed ID: 29476688
[TBL] [Abstract][Full Text] [Related]
26. The association between adolescent cannabis use and anxiety: A parallel process analysis.
Duperrouzel J; Hawes SW; Lopez-Quintero C; Pacheco-Colón I; Comer J; Gonzalez R
Addict Behav; 2018 Mar; 78():107-113. PubMed ID: 29149635
[TBL] [Abstract][Full Text] [Related]
27. Co-localization of the cannabinoid type 1 receptor with corticotropin-releasing factor-containing afferents in the noradrenergic nucleus locus coeruleus: implications for the cognitive limb of the stress response.
R Wyrofsky R; Reyes BAS; Van Bockstaele EJ
Brain Struct Funct; 2017 Sep; 222(7):3007-3023. PubMed ID: 28255675
[TBL] [Abstract][Full Text] [Related]
28. Anxiety Sensitivity and Distress Intolerance as Predictors of Cannabis Dependence Symptoms, Problems, and Craving: The Mediating Role of Coping Motives.
Farris SG; Metrik J; Bonn-Miller MO; Kahler CW; Zvolensky MJ
J Stud Alcohol Drugs; 2016 Nov; 77(6):889-897. PubMed ID: 27797690
[TBL] [Abstract][Full Text] [Related]
29. Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis.
Bortolato M; Bini V; Tambaro S
Pharmaceuticals (Basel); 2010 Aug; 3(9):2799-2820. PubMed ID: 27713377
[TBL] [Abstract][Full Text] [Related]
30. Psychiatric Symptoms, Salivary Cortisol and Cytokine Levels in Young Marijuana Users.
Cloak CC; Alicata D; Ernst TM; Chang L
J Neuroimmune Pharmacol; 2015 Jun; 10(2):380-90. PubMed ID: 25875137
[TBL] [Abstract][Full Text] [Related]
31. Cannabis use and anxiety: is stress the missing piece of the puzzle?
Temple EC; Driver M; Brown RF
Front Psychiatry; 2014; 5():168. PubMed ID: 25505428
[TBL] [Abstract][Full Text] [Related]
32. Long-term consequences of adolescent cannabinoid exposure in adult psychopathology.
Renard J; Krebs MO; Le Pen G; Jay TM
Front Neurosci; 2014; 8():361. PubMed ID: 25426017
[TBL] [Abstract][Full Text] [Related]
33. Momentary positive and negative affect preceding marijuana use events in youth.
Shrier LA; Ross CS; Blood EA
J Stud Alcohol Drugs; 2014 Sep; 75(5):781-9. PubMed ID: 25208196
[TBL] [Abstract][Full Text] [Related]
34. Individual and contextual predictors of severity of marijuana use events among young frequent users.
Shrier LA; Walls C; Rhoads A; Blood EA
Addict Behav; 2013 Jan; 38(1):1448-56. PubMed ID: 23010685
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.
Tambaro S; Bortolato M
Recent Pat CNS Drug Discov; 2012 Apr; 7(1):25-40. PubMed ID: 22280339
[TBL] [Abstract][Full Text] [Related]
36. Immediate antecedents of marijuana use: an analysis from ecological momentary assessment.
Buckner JD; Crosby RD; Silgado J; Wonderlich SA; Schmidt NB
J Behav Ther Exp Psychiatry; 2012 Mar; 43(1):647-55. PubMed ID: 21946296
[TBL] [Abstract][Full Text] [Related]
37. Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.
Serrano A; Parsons LH
Pharmacol Ther; 2011 Dec; 132(3):215-41. PubMed ID: 21798285
[TBL] [Abstract][Full Text] [Related]
38. Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.
Sidhpura N; Parsons LH
Neuropharmacology; 2011 Dec; 61(7):1070-87. PubMed ID: 21669214
[TBL] [Abstract][Full Text] [Related]
39. Anxiety sensitivity and marijuana use: an analysis from ecological momentary assessment.
Buckner JD; Zvolensky MJ; Smits JA; Norton PJ; Crosby RD; Wonderlich SA; Schmidt NB
Depress Anxiety; 2011 May; 28(5):420-6. PubMed ID: 21449005
[TBL] [Abstract][Full Text] [Related]
40. Modulation of the serotonin system by endocannabinoid signaling.
Haj-Dahmane S; Shen RY
Neuropharmacology; 2011 Sep; 61(3):414-20. PubMed ID: 21354188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
